27Feb 2024
DOACs Safe and Effective for Thromboprophylaxis After Cancer Surgery

DOACs Safe and Effective for Thromboprophylaxis After Cancer Surgery

A recent study comparing direct oral anticoagulants (DOACs) to low-molecular-weight heparin (LMWH) for thromboprophylaxis after cancer surgery found DOACs to be similarly effective in preventing venous thromboembolic events (VTE). Analyzing data involving over 3000 patients, researchers concluded that DOACs did not increase the risk of VTE, major bleeding, or clinically relevant non-major bleeding compared to LMWH within the 30-day postoperative period. This suggests DOACs could be viable options for thromboprophylaxis in cancer surgery patients.

  • #oncology

Like

Save

Share